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Objective: The study aimed to determine the bone effect of combined therapy of virgin coconut oil (VCO) and palm oil tocotrienol-
rich fraction (TRF) on biomechanical bone strength parameters of the ovariectomised rat model fed with high fat diet and heated palm 
oil. Materials and Methods: Thirty-six right femora of female Sprague-Dawley rats were obtained from the previous study at 
Universiti Kebangsaan Malaysia (UKM). The bone samples were divided into six groups with six femora in each group: Sham-
operated (SHAM), ovariectomised control (OVX), ovariectomised and given Premarin 64.5µg/kg (OVX+P), ovariectomised and given 
VCO 1.43ml/kg (OVX+V), ovariectomised and given TRF 30mg/kg (OVX+T) and ovariectomised and given combined therapy of 
VCO and TRF (OVX+VT); for 24 weeks of treatment. The right femora were wrapped completely in Phosphate Buffered Solution 
(PBS)-soaked gauze and aluminum foil and kept in the freezer (-80ºC). In the present study, the right femora were thawed at room 
temperature (25ºC) for two hours. The femora were analyzed for three-point bending test using Shimadzu, AG-X 500N machine 
controlled by proprietary software (Trapezium X Version 1.00, Shimadzu). Results: The data was tested for normality using the 
Kolmogorov-Smirnov test. The results showed that the data were normally distributed. The statistical tests used were the analysis of 
variance (ANOVA), followed by Tukey’s HSD test. The Young modulus value of OVX+VT group was significantly higher than 
OVX+V and OVX+T groups (p<0.05). Conclusion: Combined supplementation of VCO and TRF have offered better bone protective 
effects than single supplementation with VCO or TRF in preventing bone loss of osteoporotic rat model. 
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1. Introduction 
 Osteoporosis can be defined as progressive 
systemic disease characterized by low bone mass and 
loss of bone tissue with a consequent increased risk of 
fracture1. Post-menopausal women have higher 
tendency to get osteoporosis compared to men due to 
oestrogen deficiency which led to reduced protection 
against oxidative stress2. 
 The most important treatment is oestrogen 
replacement therapy (ERT), the gold standard treatment 
for post-menopausal osteoporosis. Unfortunately, 
prolonged use of this treatment causes long term 
adverse effects such as breast cancer, coronary heart 
disease, stroke and dementia3. These findings led for 
looking to the herbal supplementation in treating 
postmenopausal osteoporosis.  
 Virgin coconut oil (VCO) is one of the natural 
antioxidant-rich diets that can prevent bone loss caused 
by osteoporosis4. The single dose of VCO given to the 
ovariectomised rats resulted in improved bone structure 
and prevented bone loss due to its high polyphenols 
components which exert antioxidant property5.  
 Furthermore, the other antioxidant-rich diet is 
palm oil tocotrienol-rich fraction (TRF) which has a 
major source of the fat-soluble vitamin E. TRF 
supplementation in ovariectomised rats, could improve 
bone biomechanical strength when tested 
biomechanically6.  
 The current study was designed to determine the 
effects of both VCO and TRF, individually and in 
combination, on bone biomechanical properties (load, 
displacement, stiffness, stress, strain and Young 
modulus) of the ovariectomised rat fed with high 
cholesterol diet and repeatedly-heated palm oil. 
2. Materials and Methods 
Femora were harvested from a previous study 
(Approval No. UKMAEC: 
FP/ANAT/2014/FAIZAH/16-JULY/599-JULY-2014-
SUG-2015-NAR-CAT2) on Sprague-Dawley rats 
conducted at Universiti Kebangsaan Malaysia (UKM). 
The femora were obtained from six different groups of 
female Sprague-Dawley rats. Sham-operated group 
(SHAM) fed on rat chow diet whereas the 
ovariectomised (OVX) control group was given 15% of 
five times heated palm oil (5HPO) mixed with 2% 
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cholesterol. The ovariectomised-treated groups were 
given 64.5µg/kg of Premarin (OVX+P), 1.43 ml/kg of 
virgin coconut oil (OVX+V), 30mg/kg of TRF 
(OVX+T) and combination of 1.43 ml/kg of VCO and 
30mg/kg of TRF (OVX+VT). 
 Each right femur was wrapped with gauze 
soaked in Phosphate Buffered Solution (PBS) and 
rewrapped with aluminum foil to keep moist at all times 
in -80ºC freezer until use. On the day of testing, the 
femora were allowed to thaw at room temperature for 2 
hours. 
 In this study, biomechanical properties of the 
right femoral bones were conducted using three-point 
bending test using the Universal Testing machine 
(Model Shimadzu, AG-X 500N) controlled by 
proprietary software (Trapezium X Version 1.00, 
Shimadzu). The parameters of the biomechanical 
strength were divided into the extrinsic parameters 
(load, displacement and stiffness) and the intrinsic 
parameters (stress, strain and Young modulus).  
The data analysis was performed using the 
Statistical Package for Social Sciences software (SPSS 
25; Chicago, IL, USA). The data was tested for 
normality using the Kolmogorov-Smirnov test 
(n=<100) and showed normally distributed data. Thus, 
the statistical tests used were the analysis of variance 




Figure 1: Maximum load value for all groups.  
 
 Figure 2: Maximum displacement value for all groups.  





Figure 3: Maximum stiffness value for all groups.  
a* p<0.05 compared to the SHAM group                       
b* p<0.05 compared to the OVX group 
 Figure 4: Maximum stress value for all groups.  





Figure 5: Maximum strain value for all groups.  
a* p<0.05 compared to the SHAM group 
b* p<0.05 compared to the OVX group 
 Figure 6: Young modulus value for all groups.   
a* p<0.05 compared to the SHAM group                   
b* p<0.05 compared to the OVX group 
c* p<0.05 compared to the OVX+P group 
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 The current study showed significant 
improvement in both extrinsic and intrinsic parameters. 
For extrinsic parameters, there was an increasing trend 
of displacement value between the treated groups 
(OVX+V, OVX+T and OVX+VT) compared to the 
OVX group. This showed that ovariectomised rats 
given these supplementations produced more ductile 
bones, hence they were harder to break. The result 
matched with previous studies which reported that 
decreased oestrogen level via ovariectomy led to 
decreased in cortical bone strength2. Nevertheless, other 
extrinsic parameters such as load and stiffness showed 
no statistical difference between all groups. 
 For intrinsic parameters, the OVX+T group 
showed more superior strain value than both OVX+V 
and OVX+VT groups. The result showed that 
supplementation with TRF offered the best protection 
against osteoporosis as shown by the significantly 
higher value than ovariectomised control group. Young 
modulus and maximum stress values of OVX+VT 
group was better than OVX+V and OVX+T groups. 
Thus, combined supplementation of VCO and TRF 
(OVX+VT group), have offered better bone protective 
effects than single supplementation with VCO or TRF. 
5. Conclusion 
Combined supplementation of VCO and TRF have 
offered better bone protective effects than single 
supplementation with VCO or TRF in preventing bone 
loss of osteoporotic rat model. 
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